INS and metabolic syndrome: Overexpression of inflammatory factors such as serum C-reactive protein, interleukin (IL)-6, and tumor necrosis factor-α can inhibit insulin secretion and islet function and leads to insulin secretion disorder and insulin resistance, resulting in insufficient insulin secretion and inability to lower blood glucose levels, leading to T2DM and metabolic syndrome [24].